Cbe, ma (Oxon), mbchB, bsc (Hons), msc, PhD, md, dsc, frcp (Glasgow,Edinburgh and London), frcgp (hon), fcanSci, fmedSci
Download 443.19 Kb.
|
- Navigate this page:
- INTERNATIONAL COLLABORATIONS
- RESEARCH GRANTS RECEIVED
INTERACTION WITH INDUSTRYI have established board level links with a number of global pharmaceutical and healthcare companies which has led to significant grant funding eg Glaxo Smith Kline (£3 million), Merck (£14 million), Roche (£6.5 million) GE Healthcare (£2 million) and AstraZeneca (£1 million). I was part of the Drug Development Team which won Astra Zeneca’s Oncology and Infections Visions and Values prize in 2005. Oxford has an impressive record of protecting and developing its IPR and establishing spin out companies. When working in the University of Birmingham, I established one of their first biotechnology spin outs, a gene therapy company, COBRA Therapeutics. In Oxford, I have worked with ISIS to construct a cancer drug development company, Celleron and Oxford Cancer Biomarkers a platform technology-based biotech company which identifies chemotherapy sensitivity biomarkers. INTERNATIONAL COLLABORATIONS:USA I sit on NIH’s Translational Research working group as the overseas member and have established a series of collaborations with the USA’s major cancer research centres (Mayo Clinic, MD Anderson, Memorial Sloan Kettering and Dana Farber, Harvard). INDIA having attracted grant funding from the pharmaceutical company GSK, we have constructed a network of India’s top 10 cancer centres, in partnership with Oxford. This collaboration will provide training opportunities for Indian investigators in Oxford and will build an internationally competitive clinical research network (www.indox.org.uk). EUROPE I had the opportunity to co-chair the Entente Cordiale Celebrations on behalf of HM the Queen and President Chirac, 2003-2005. As President of ESMO (2010-2012) I am in a strong position to improve standing of Medical Oncology in Europe and sit on the Dutch government’s central committee for translational research with a budget of 1 billion Euros. AFRICA I have established a consortium comprising the International Atomic Energy Agency, International Agency for Cancer Research, and the Union Internationals Contre Le Cancer to develop cancer control programmes in Sub Saharan Africa and created AfrOx (www.afrox.org) the vehicle to implement change. FAR EAST I have established OxOnics, a drug development company with my colleague Dr Wenn Sun. It has a mission to bring novel anti-cancer agents to the Asia-pacific rim with a focus on China. RESEARCH GRANTS RECEIVED1989
One year's salary for Research Assistant.
as part of an international collaborative group chaired by Prof S S Davis, Dept. Pharmacy, University of Nottingham
3 years' salary - clinical research fellow & post doctoral scientist for research into use of Mitomycin C microcapsules by intrahepatic arterial administration in hepatic metastatic carcinoma. Grant Holders - D Kerr, C McArdle, A Whately. 1990
2 year's salary for research assistant - molecular biology of breast cancer
Joint project with Dr I Pragnell, Beatson Institute for Cancer Research, funding a clinical research fellow to investigate preclinical toxicology of marrow stem cell inhibitor 1991
3 year salary for senior post-doctoral scientist for project on population pharmacokinetics of cytotoxic drugs in breast cancer therapy
Supervision of programme grant expenditure of CRC Pharmacology Group - 5 year programme Grant. 1992
2 year's salary for senior post-doctoral scientist for project on formulation of cytotoxic drugs for cerebral implantation in the treatment of brain tumours. Grant Holders - D J Kerr, T A Whately, R Rampling, J Plumb
Development of Inhibitors of P-Glycoprotein. Grant Holders - D J Kerr, D R Ferry
Interaction of Platinum with the HIV Promoter Sequence. Grant Holders - D J Kerr, C J Poole, L Young
Laboratory Refurbishment grant on joining University of Birmingham Grant Holder – D J Kerr
Molecular Pharmacology Group Grant Holder – D J Kerr
Programme Grant Supporting Clinical Trials Unit Grant Holder – D J Kerr 1994
To house the expanding Institute for Cancer Studies Grant holder - D J Kerr September 1995-September 1999
Gene Therapy of Common Cancers: Immunological & Pharmacological Approaches to Gynaecological Cancer. Grant holders - LS Young, PF Searle, D. Luesley, AB Rickinson, PH. Gallimore
Departments Expenses-Core Funding 1995-1999 Grant holders - AB Rickinson and DJ Kerr September 1994-September 1997
A Co-administration of rising oral GG918 Dose Levels with Doxorubicin Phase 1 Study Grant holders - DJ Kerr January 1995-January 1998
Adjuvant Intraperitoneal Chemotherapy with 5-fluorouracil in Duke’s Stage B and C Colic Adenocarcinoma (VICTOR) Grant holder - DJ Kerr November 1995-November 1997
Investigation of Phospholipase Signal Transduction Pathways in Human Breast Cancer Grant holders - DJ Kerr and MJO Wakelam March 1997-March 1998
A Phase II Open Label Study to Determine the Safety Tolerability and Efficacy of CV6504(HCI) in Patients with pancreatic cancer Grant holders - DJ Kerr September 1996-September 1999
Immunological and Pharmacological Aspects of Gene Therapy Grant holders - DJ Kerr 1996-2001
Core Clinical Fellowships Grant holders - DJ Kerr 1997-2001
Clinical Trials Unit – Core Support Grant holders - DJ Kerr 1995-1998
West Midlands Trials of Adjuvant Treatment in Early Breast Cancer Grant holder - DJ Kerr 1998-2003
Pre-Clinical and Clinical Pharmacology and Macromolecular Drug Targeting Grant holder - DJ Kerr 1998-2002
ATTOM UKCCCR Randomised Trial to Establish Optimum Length of Adjuvant Tamoxifen Grant holder - DJ Kerr 1994-1997
Evaluation of Non-Nutrient Dietary Constituents in Prevention of Breast Cancer Grant holders - DJ Kerr, A Gescher, K. Chipman 1997
Research and Development for a Boron Cancer Therapy Clinical Facility Grant holders - DJ Kerr, N James, D. Beynon 1996-2001
Foundation of a Regional Clinical Trials Unit Grant holders - DJ Kerr, R Hobbs, L Ward, J Dunn, J Kenkre 1994-1999
QUASAR Adjuvant Trial of Colorectal Cancer Chemotherapy Grant holders - DJ Kerr and R Gray 1998
Construction of a clinical research facility Grant holders – M Sheppard, P Stewart, DJ Kerr, M Wakelam, LS Young, AB Rickinson, C Savage 1998-2003
Co-operative Group – Translational Research: Gene and Immunotherapy of Cancer. Grant holders: DJ Kerr, DH Adams, PAH Moss, V Mautner, PF Searle, L Seymour and LS Young
Joint Research Equipment Initiative Award Grant Holders: P Moss, A Rickinson, D Kerr, J Gordon, L Young C Bunce 1997-2002
Clinical Trials Grant for Adjuvant Colorectal Cancer Trial: PETACC
FOCUS : trial of chemotherapy in advanced colorectal cancer Grant Holders: M Seymour, R James, D J Kerr, T Maugham and R Stephens Recently awarded grants MERCK – Cancer Research Campaign £12.6 million – 2002 – 2009 Trial of adjuvant therapy with cyclooxygenase inhibitors in colorectal cancer Grant Holder: D J Kerr
Adjuvant trial of chemotherapy for colorectal cancer Grant Holder: D J Kerr
Proteomic investigation of colorectal cancer Grant holder: D J Kerr
To establish the National Translational Cancer Research Network (NTRAC) and the National Cancer Tissue Resource (NCTR). Grant Holder: D J Kerr E-Science Pilot Project in Integrative Biology - £ 1,244 310 Lead investigator: D Gavaghan Co-investigator: D J Kerr CRUK Gene Therapy Programme Grant - £1.2 million - 2004 - 2009 Lead investigator: L Seymour Co-investigator: D J Kerr
Lead investigators: D J Kerr and I Tomlinson GE Healthcare: Molecular Basis of Colorectal Cancer - £2.4 million – 2005-2007 Lead Investigator: D J Kerr Cancer Research UK, Research Grant, ECMC Award - CRUK funding for the experimental cancer medicine centre - £3,070,410 - 2007 – 2012 Lead investigator: A Harris Co-investigator: D J Kerr
Lead investigator: P Boyle Co-investigator: D J Kerr SCOT Study ad adjuvant colorectal cancer chemotherapy: MRC £1,798,433 – 2006- 2014 Lead investigator: J Cassidy Co-investigator: D J Kerr Roche Ltd: £1.5 million – 2012 – current Lead Investigator: DJ Kerr Oxford Cancer Biomarkers: £3.25 million – 2011- current Download 443.19 Kb. Share with your friends:
|